Minims Tropicamide Bausch + Lomb Ireland Limited

Tropicamide, the active ingredient in Minims Tropicamide, is an antimuscarinic presented as an ophthalmic solution for ocular use. It produces reversible pupil dilation and cycloplegia, facilitating detailed examination of the interior of the eye and aiding certain diagnostic procedures.

GNH USA supplies Minims Tropicamide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Tropicamide is a mydriatic agent used in ophthalmic practice to achieve pupil dilation.

- Mydriasis for eye examination: provides rapid pupil dilation to allow thorough retinal and optic nerve evaluation. - Cycloplegia for refraction: temporarily paralyzes the ciliary muscle to obtain accurate measurement of refractive error. - Pre‑operative dilation for intraocular surgery: creates a wide pupil to facilitate surgical access and visualization.

Tropicamide may cause a range of ocular and systemic reactions.

Common Side Effects: - Stinging or burning sensation upon instillation. - Transient blurred vision due to pupil dilation. - Photophobia (light sensitivity) while the pupil remains enlarged. - Mild increase in intra‑ocular pressure in susceptible individuals. - Temporary redness of the conjunctiva.

Serious or Rare Side Effects: - Acute angle‑closure glaucoma, presenting with severe eye pain and visual loss. - Allergic reactions such as eyelid edema, rash, or urticaria. - Systemic anticholinergic effects (e.g., dry mouth, tachycardia) in rare cases of excessive absorption.

Before using Minims Tropicamide, consider the following precautions. - Assess intra‑ocular pressure: avoid use in patients with uncontrolled glaucoma. - Contraindicated in narrow‑angle glaucoma: risk of precipitating angle‑closure. - Use only under professional supervision: ensure proper technique and dosing. - Monitor for allergic reactions: discontinue if signs of hypersensitivity appear. - Store at room temperature: keep bottle tightly closed, protect from light and moisture.

Tropicamide can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic anticholinergics (e.g., atropine): additive anticholinergic effects may increase systemic toxicity. - Miotic agents (e.g., pilocarpine): antagonistic action reduces desired pupil dilation.

Moderate Interactions (Monitor Closely): - Topical ophthalmic anesthetics: may increase corneal toxicity when used together. - Beta‑blocker eye drops: monitor intra‑ocular pressure as combined effects can alter pressure control. - Other cycloplegic agents (e.g., cyclopentolate): additive cycloplegia may prolong visual impairment.